Use the Back button in your browser to see the other results of your search or to select another record.
Efficacy and safety of Supine Daoyin in the treatment of acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial |
Li J, Zhang H, Wang J, Lu X, Zuo M, Jiao L, Lu X, Wang Y |
Journal of Evidence-Based Medicine 2024 Sep;17(3):654-666 |
clinical trial |
7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|